2007
DOI: 10.1530/eje-07-0148
|View full text |Cite
|
Sign up to set email alerts
|

Genetic disorders in the GH–IGF-I axis in mouse and man

Abstract: Animal knockout experiments have offered the opportunity to study genes that play a role in growth and development. In the last few years, reports of patients with genetic defects in GH-IGF-I axis have greatly increased our knowledge of genetically determined causes of short stature. We will present the animal data and human reports of genetic disorders in the GH-IGF-I axis in order to describe the role of the GH-IGF-I axis in intrauterine and postnatal growth. In addition, the effects of the GH-IGF-I axis on … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
37
1
4

Year Published

2008
2008
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 65 publications
(45 citation statements)
references
References 128 publications
(164 reference statements)
3
37
1
4
Order By: Relevance
“…been presented in earlier reports; thus it remains to be established whether microcephaly represents a clinical feature of homozygous ALS deficiency. The growth pattern in humans with ALS deficiency is comparable with the mild growth failure observed in ALS gene knock-out (ALS-KO) mice, and is in contrast with the severe growth failure as observed in patients with a total IGF-I deficiency (2). This is in line with the hypothesis that the contribution of locally produced IGF-I to longitudinal growth is more important than that of IGF-I derived from the circulation (10,17).…”
Section: Discussionsupporting
confidence: 78%
See 2 more Smart Citations
“…been presented in earlier reports; thus it remains to be established whether microcephaly represents a clinical feature of homozygous ALS deficiency. The growth pattern in humans with ALS deficiency is comparable with the mild growth failure observed in ALS gene knock-out (ALS-KO) mice, and is in contrast with the severe growth failure as observed in patients with a total IGF-I deficiency (2). This is in line with the hypothesis that the contribution of locally produced IGF-I to longitudinal growth is more important than that of IGF-I derived from the circulation (10,17).…”
Section: Discussionsupporting
confidence: 78%
“…Puberty onset was reported to have occurred between 12 and 14 years. Total BMD at 6, 10, and 12 years of age was 0.68 (K1.3 SDS), 0.76 (K1.2 SDS), and 0.62 g/cm 2 (K2.0 SDS) respectively. The GH peak after exercise was high (118 mU/l), IGF-I was very low (K4.2 to K3.8 SDS), and IGFBP-3 extremely low (!K17 SDS).…”
Section: Medical History Of the Als-deficient Patientsmentioning
confidence: 98%
See 1 more Smart Citation
“…However, our patient seems to have secreted estrogen sufficiently because she had her periods before the tumor developed. Therefore GH secretion may have been promoted probably because of increased GHRH secretion if she was in a state of GH/IGF-I insensitivity (26,27). A previous study showed that excessive GH secretion resulted in upregulated somatotrope proliferation and neoplastic transformation in animal models and human (28).…”
Section: T a B L E 6 P I T U I T A R Y T U Mo R S I N T U R N E R Smentioning
confidence: 99%
“…The insulin-like growth factors (IGFs) are powerful mitogenic agents that stimulate cell differentiation and inhibit apoptosis (Walenkamp and Wit, 2007). IGF2, located on chromosome 11p15.5, also known as somatomedin A, is a single-chain polypeptide that shares an amino acid sequence homology of about 47% with insulin and 31% with relaxin.…”
Section: Introductionmentioning
confidence: 99%